Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TIL Instil Bio, Inc.

已收盘 11-05 16:00:00 EST

26.46

-1.17

-4.23%

盘后26.46

+0.000.00%

19:30 EST

最高28.19	最低26.43	成交量9.19万
今开27.05	昨收27.63	日振幅6.39%
总市值1.72亿	流通市值6,119万	总股本650.39万
成交额249.63万	换手率3.98%	流通股本231.25万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TIL","market":"US","secType":"STK","nameCN":"Instil Bio, Inc.","latestPrice":26.46,"timestamp":1730840400000,"preClose":27.63,"halted":0,"volume":91948,"hourTrading":{"tag":"盘后","latestPrice":26.46,"preClose":26.46,"latestTime":"19:30 EST","volume":1315,"amount":34797.07,"timestamp":1730853003857},"delay":0,"floatShares":2312507,"shares":6503913,"eps":-18.388937,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.17,"latestTime":"11-05 16:00:00 EST","open":27.05,"high":28.19,"low":26.425,"amount":2496349.7657359997,"amplitude":0.06388,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.388937,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730883600000},"adr":0,"listingDate":1616126400000,"adjPreClose":27.63,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":27.78,"preClose":27.63,"latestTime":"09:28 EST","volume":202,"amount":5610.560302,"timestamp":1730816909086},"postHourTrading":{"tag":"盘后","latestPrice":26.46,"preClose":26.46,"latestTime":"19:30 EST","volume":1315,"amount":34797.07,"timestamp":1730853003857},"volumeRatio":0.494476,"impliedVol":5.6162,"impliedVolPercentile":0.96},"requestUrl":"/m/hq/s/TIL","defaultTab":"news","newsList":[{"id":"2481554215","title":"Instil Bio, Inc.盘中异动 股价大跌5.00%报27.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481554215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481554215?lang=zh_cn&edition=full","pubTime":"2024-11-05 05:00","pubTimestamp":1730754059,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日05时00分，Instil Bio, Inc.股票出现波动，股价快速下挫5.00%。截至发稿，该股报27.34美元/股，成交量12.5921万股，换手率1.94%，振幅6.78%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105050059971a43ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105050059971a43ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2480065931","title":"Instil Bio, Inc.盘中异动 临近收盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480065931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480065931?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:36","pubTimestamp":1730403366,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时36分，Instil Bio, Inc.股票出现波动，股价大幅下挫5.25%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为3.33%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101033607971a39f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101033607971a39f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2478102489","title":"Instil Bio, Inc.盘中异动 快速上涨6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478102489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478102489?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122277,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分，Instil Bio, Inc.股票出现异动，股价大幅上涨6.18%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213117a1f24c97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213117a1f24c97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2478810923","title":"在外部环境挑战下，药明康德2024年前三季度收入和利润环比持续提升；第三季度收入重回百亿规模，剔除新冠商业化项目同比增长14.6%；在手订单同比增长35.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478810923","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478810923?lang=zh_cn&edition=full","pubTime":"2024-10-28 19:04","pubTimestamp":1730113440,"startTime":"0","endTime":"0","summary":"截至2024年9月底，公司在手订单438.2亿元，同比增长35.2%。前三季度，来自于全球前20大制药企业收入达到人民币112.2亿元，剔除新冠商业化项目同比增长23.1%。管理层评论 药明康德董事长兼首席执行官李革博士表示：\"在外部环境挑战下，公司2024年前三季度收入及利润按计划环比稳步提升；第三季度收入重回百亿规模，剔除新冠商业化项目同比增长14.6%，同时在手订单实现人民币438.2亿，同比增长35.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4541331_ZH41331_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1141","02359","LU2045819591.USD","WUXAY","BK4139","LU0708995583.HKD","LU1046422090.SGD","LU2125910500.SGD","LU2242644610.SGD","LU1997245177.USD","BK1576","BK4505","LU2488822045.USD","TIL","BK0216","LU0320764599.SGD","603259","LU1997245094.SGD","LU0456842615.SGD","BK4121","BK1583","LU0052750758.USD"],"gpt_icon":0},{"id":"2478551499","title":"Instil Bio, Inc.盘中异动 股价大涨5.08%报32.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478551499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478551499?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:08","pubTimestamp":1729872490,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时08分，Instil Bio, Inc.股票出现波动，股价快速上涨5.08%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为821.69%、745.83%、231.45%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Iterum Therapeutics Plc、Elevai Labs, Inc.，振幅分别为91.58%、90.60%、85.68%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026000810ab744fd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026000810ab744fd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2477565022","title":"Instil Bio, Inc.盘中异动 临近收盘快速下挫5.30%报31.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477565022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477565022?lang=zh_cn&edition=full","pubTime":"2024-10-24 03:36","pubTimestamp":1729712165,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日03时36分，Instil Bio, Inc.股票出现波动，股价急速下挫5.30%。截至发稿，该股报31.80美元/股，成交量4.8537万股，换手率0.75%，振幅7.00%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.45%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024033605971a1dfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024033605971a1dfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2477241203","title":"2024，细胞疗法实体瘤爆发元年","url":"https://stock-news.laohu8.com/highlight/detail?id=2477241203","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477241203?lang=zh_cn&edition=full","pubTime":"2024-10-23 13:48","pubTimestamp":1729662533,"startTime":"0","endTime":"0","summary":"如何来定义2024年的全球创新药？但对于身处其中的细胞疗法来说，答案已经跃然纸上：细胞疗法实体瘤的爆发元年。2月16日，Iovance 的Lifileucel获得FDA加速批准上市，用于治疗PD-1抗体治疗后进展的黑色素瘤。这意味着，细胞疗法开始迈入实体瘤时代。8月1日，Adaptimmune宣布，FDA已加速批准其TCR-T疗法Tecelra上市，用于治疗无法切除或转移性的滑膜肉瘤成人患者。这标志着，细胞疗法在实体瘤治疗领域又迈出了重要的一步。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/242764","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["TIL","BK4139","BK4022","BK4505","CAR","BK4230"],"gpt_icon":0},{"id":"2477862519","title":"Instil Bio, Inc.盘中异动 急速下跌5.26%报35.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477862519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477862519?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:53","pubTimestamp":1729522433,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时53分，Instil Bio, Inc.股票出现异动，股价快速跳水5.26%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为5200.68%、2812.83%、1162.65%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Aptevo Therapeutics Inc.，振幅分别为323.73%、157.02%、118.79%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021225353a1e24ddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021225353a1e24ddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2476674922","title":"Instil Bio, Inc.盘中异动 股价大跌5.41%报37.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476674922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476674922?lang=zh_cn&edition=full","pubTime":"2024-10-19 00:58","pubTimestamp":1729270701,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日00时58分，Instil Bio, Inc.股票出现异动，股价大幅下挫5.41%。截至发稿，该股报37.32美元/股，成交量2.4938万股，换手率0.38%，振幅5.35%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019005822971a1293&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019005822971a1293&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","TIL"],"gpt_icon":0},{"id":"2475395924","title":"Instil Bio, Inc.盘中异动 大幅拉升5.99%报44.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475395924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475395924?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:29","pubTimestamp":1728916175,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时29分，Instil Bio, Inc.股票出现异动，股价快速上涨5.99%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101422293698e3c4c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101422293698e3c4c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2474801037","title":"Instil Bio, Inc.盘中异动 下午盘股价大涨5.52%报39.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474801037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474801037?lang=zh_cn&edition=full","pubTime":"2024-10-12 01:15","pubTimestamp":1728666932,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日01时15分，Instil Bio, Inc.股票出现波动，股价快速拉升5.52%。截至发稿，该股报39.56美元/股，成交量6.6411万股，换手率1.02%，振幅9.52%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120115329719fbb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120115329719fbb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2474741377","title":"Instil Bio, Inc.盘中异动 大幅下跌5.46%报36.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474741377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474741377?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:52","pubTimestamp":1728568350,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时52分，Instil Bio, Inc.股票出现异动，股价大幅下跌5.46%。截至发稿，该股报36.55美元/股，成交量6629股，换手率0.10%，振幅3.98%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021523198e3bbb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021523198e3bbb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2474422502","title":"Instil Bio, Inc.盘中异动 股价大涨5.17%报37.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474422502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474422502?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:39","pubTimestamp":1728481193,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时39分，Instil Bio, Inc.股票出现波动，股价快速拉升5.17%。截至发稿，该股报37.44美元/股，成交量1.405万股，换手率0.22%，振幅6.85%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009213953a1df6b44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009213953a1df6b44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2473782544","title":"Instil Bio, Inc.盘中异动 急速下挫5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473782544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473782544?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:44","pubTimestamp":1728395083,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时44分，Instil Bio, Inc.股票出现波动，股价急速跳水5.60%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Bio-Path Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virios Therapeutics, Inc.涨幅较大，Virios Therapeutics, Inc.、Aditxt, Inc.、Bio-Path Holdings, Inc.较为活跃，换手率分别为2896.97%、2034.75%、1698.28%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Virios Therapeutics, Inc.、Aditxt, Inc.，振幅分别为28.18%、25.96%、25.50%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008214444a1df0ed6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008214444a1df0ed6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2472963199","title":"Instil Bio, Inc.盘中异动 快速上涨5.35%报55.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472963199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472963199?lang=zh_cn&edition=full","pubTime":"2024-10-04 22:36","pubTimestamp":1728052586,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日22时36分，Instil Bio, Inc.股票出现异动，股价急速上涨5.35%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100422362698e3a9e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100422362698e3a9e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","TIL"],"gpt_icon":0},{"id":"2472850387","title":"Instil Bio, Inc.盘中异动 急速下跌5.21%报58.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472850387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472850387?lang=zh_cn&edition=full","pubTime":"2024-10-03 03:03","pubTimestamp":1727895829,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日03时03分，Instil Bio, Inc.股票出现异动，股价快速下跌5.21%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100303035098e3a423&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100303035098e3a423&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","TIL"],"gpt_icon":0},{"id":"2471599385","title":"Instil Bio, Inc.盘中异动 大幅上涨5.73%报69.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471599385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471599385?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:48","pubTimestamp":1727704126,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时48分，Instil Bio, Inc.股票出现异动，股价大幅上涨5.73%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930214847a1ddb528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930214847a1ddb528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2470034503","title":"Instil Bio, Inc.盘中异动 股价大跌5.95%报64.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470034503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470034503?lang=zh_cn&edition=full","pubTime":"2024-09-28 00:48","pubTimestamp":1727455721,"startTime":"0","endTime":"0","summary":"北京时间2024年09月28日00时48分，Instil Bio, Inc.股票出现异动，股价快速下跌5.95%。截至发稿，该股报64.29美元/股，成交量5.4591万股，换手率0.84%，振幅6.76%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240928004842ab668982&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240928004842ab668982&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"gpt_icon":0},{"id":"2470751137","title":"中国细胞和基因疗法或迎爆发，拜耳亚太最大共创平台在沪落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2470751137","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470751137?lang=zh_cn&edition=full","pubTime":"2024-09-27 16:19","pubTimestamp":1727425186,"startTime":"0","endTime":"0","summary":"蓝鲸新闻9月27日讯 细胞与基因治疗，被誉为继药物治疗、手术治疗后的第三次医学革命。2024年可以说是中国细胞和基因治疗爆发的一年。据悉，拜耳Co.Lab中国将赋能8至10家初创企业，重点关注细胞和基因疗法、肿瘤以及新技术平台等前沿创新领域。此次，拜耳Co.Lab共创平台首次落地中国，这也是拜耳在亚太地区所设立的最大共创平台。数据显示，细胞与基因治疗领域的药物开发，大多数药物开发集中于肿瘤以及罕见疾病领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/241121","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2469494045","title":"Instil Bio, Inc.盘中异动 早盘股价大涨5.19%报71.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469494045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469494045?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:47","pubTimestamp":1727185632,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时47分，Instil Bio, Inc.股票出现异动，股价大幅上涨5.19%。截至发稿，该股报71.00美元/股，成交量1.4106万股，换手率0.22%，振幅7.42%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242147129719c64e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242147129719c64e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"https://instilbio.com/","stockEarnings":[{"period":"1week","weight":-0.2171},{"period":"1month","weight":-0.4301},{"period":"3month","weight":1.4237},{"period":"6month","weight":1.4538},{"period":"1year","weight":2.684},{"period":"ytd","weight":2.626}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Instil Bio, Inc.总部位于德克萨斯州达拉斯，于2018年8月在特拉华州注册成立。该公司是一家临床阶段生物制药公司，致力于开发创新的自体肿瘤浸润淋巴细胞（TIL）治疗细胞疗法，以治疗癌症患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.173004},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.036947},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.080585},{"month":4,"riseRate":0.25,"avgChangeRate":-0.133235},{"month":5,"riseRate":0,"avgChangeRate":-0.094412},{"month":6,"riseRate":0.25,"avgChangeRate":-0.066045},{"month":7,"riseRate":0.5,"avgChangeRate":0.043591},{"month":8,"riseRate":0.5,"avgChangeRate":0.036497},{"month":9,"riseRate":0.25,"avgChangeRate":0.913411},{"month":10,"riseRate":0.25,"avgChangeRate":-0.209964},{"month":11,"riseRate":0.25,"avgChangeRate":-0.183759},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.207775}],"exchange":"NASDAQ","name":"Instil Bio, Inc.","nameEN":"Instil Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Instil Bio, Inc.,TIL,Instil Bio, Inc.股票,Instil Bio, Inc.股票老虎,Instil Bio, Inc.股票老虎国际,Instil Bio, Inc.行情,Instil Bio, Inc.股票行情,Instil Bio, Inc.股价,Instil Bio, Inc.股市,Instil Bio, Inc.股票价格,Instil Bio, Inc.股票交易,Instil Bio, Inc.股票购买,Instil Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}